Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Synese Jolidon

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Aminothiazoles as γ-secretase modulatorsThomas Lübbers, Alexander Flohr, Synese Jolidon, et al.
Journal of Medicinal Chemistry|May 25, 2010
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophreniaEmmanuel Pinard, Alexander Alanine, Daniela Alberati, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Aminothiazoles as γ-secretase modulatorsThomas Lübbers, Alexander Flohr, Synese Jolidon, et al.
Journal of Medicinal Chemistry|May 25, 2010
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophreniaEmmanuel Pinard, Alexander Alanine, Daniela Alberati, et al.
Pageof 1